Veradermics, Incorporated (MANE) — Cash Flow-to-Debt Ratio
Veradermics, Incorporated (MANE) has a Cash Flow-to-Debt Ratio of -3.15x as of March 2026, meaning its operating cash flow of $-21.17 Million could theoretically repay -3% of its total liabilities ($6.72 Million) in one year. See Veradermics, Incorporated short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Veradermics, Incorporated Cash Flow-to-Debt Ratio (2023–2025)
Historical debt coverage capacity for Veradermics, Incorporated across 3 annual periods. Also explore net asset growth rate of Veradermics, Incorporated to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Veradermics, Incorporated (2023–2025)
Year-by-year debt coverage analysis for Veradermics, Incorporated. For market capitalisation and broader financial context, see Veradermics, Incorporated stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.26x | $-71.60 Million | $273.63 Million | ▲ +94.8% |
| 2024 | -5.02x | $-23.69 Million | $4.72 Million | ▼ -42.6% |
| 2023 | -3.52x | $-13.51 Million | $3.84 Million | — |